- ÀÏ ½Ã
- 2021³â 4¿ù 16ÀÏ(±Ý) ~ 17ÀÏ(Åä)
- ¹æ ¹ý
- ¿Â¶óÀÎ Çмú´ëȸ
- Æò Á¡
- 4¿ù 16ÀÏ(±Ý) : 3ÆòÁ¡ | 4¿ù 17ÀÏ(Åä) : 2ÆòÁ¡ ¿¹»ó
- »çÀüµî·Ï ±â°£
- 2021³â 2¿ù 22ÀÏ(¿ù) - 4¿ù 5ÀÏ(¿ù)±îÁö
- µî ·Ï ºñ
- Àü¹®ÀÇ 30,000¿ø, Àü°øÀÇ ¹× ±âŸ 20,000¿ø
°£È£»ç ¹× ¿¬±¸¿øÀº µî·Ïºñ´Â ¾øÀ¸³ª »çÀüµî·Ï Çʼö!
- °èÁ¹øÈ£
- KEBÇϳªÀºÇà 501-910052-96405 (¿¹±ÝÁÖ : ´ëÇѼҾÆÇ÷¾×Á¾¾çÇÐȸ)
ÇÁ·Î±×·¥
4¿ù 16ÀÏ ±Ý¿äÀÏ | ||
12:30 - 13:30 | ÆòÀÇ¿øȸ | |
13:30 - 14:00 | µî·Ï | |
14:00 - 14:10 | ȸÀå´Ô, ÀÌ»çÀå´Ô Àλç | ȸÀå´Ô / ÀÌ»çÀå´Ô |
14:10 - 15:30 | Scientific Session 1: Long term survivors of childhood cancer (´ëÇѼҾÆÇ÷¾×Á¾¾çÇÐȸ/Çѱ¹¹éÇ÷º´¼Ò¾Æ¾ÏÇùȸ °øµ¿ ¼¼¼Ç) |
ÁÂÀå : ÀÌ¿µÈ£ (ÇѾçÀÇ´ë) |
14:10 - 14:50 | LTFU system and survivorship care in Japan | Dr. Yasushi Ishida (Ehime Prefectural Central Hospital, Childhealth Center) |
14:50 - 15:10 | Current status of LTFU system and survivorship care in Korea | ¹ÚÇöÁø (±¹¸³¾Ï¼¾ÅÍ) |
15:10 - 15:30 | Experience and suggestions for the establishment of optimal LTFU system and survivorship care in Korea | ¼Á¾Áø (¿ï»êÀÇ´ë/Çѱ¹¹éÇ÷º´¼Ò¾Æ¾ÏÇùȸ) |
15:30 - 15:40 | Break | |
15:40 - 17:10 | Scientific Session 2: Analysis of NGS results |
ÁÂÀå : ¼º±â¿õ (¼º±Õ°üÀÇ´ë) |
15:40 - 16:10 | NGS analysis & application in pediatric hematologic malignancy | ±è¸í½Å (°¡Å縯ÀÇ´ë) |
16:10 - 16:40 | NGS analysis & application in pediatric solid tumor | ¹èÁ¤¸ð (¼¿ïÀÇ´ë) |
16:40 - 17:10 | NGS based approach as a clinician | ÀÌÁö¿ø (¼º±Õ°üÀÇ´ë) |
17:10 - 18:00 | Case Discussion Session | °í°æ³² (¿ï»êÀÇ´ë) |
17:10 - 18:00 | Case |
4¿ù 17ÀÏ Åä¿äÀÏ | ||
09:00 - 10:00 | Special Lecture | ÁÂÀå : ±¹ ÈÆ (Àü³²ÀÇ´ë) |
09:00 - 09:40 | Current Treatment & Recent Advances in Pediatric ALL | Stephen P.Hunger (Children's Hospital of Philadelphia) |
09:40 - 10:00 | Q&A session | |
10:00 - 10:20 | Break | |
10:20 - 12:00 | KPHOG session | ÁÂÀå : À¯°ÇÈñ (¼º±Õ°üÀÇ´ë) |
10:20 - 11:20 | ¿¬±¸ ÁøÇà ¼Ò°³ | 12°³ ¿¬±¸È¸ |
11:20 - 11:50 | iCreat ¼Ò°³ | °í°æ³² (¿ï»êÀÇ´ë) |
11:50 - 12:00 | ÅäÀÇ | |
12:00 | Æóȸ |